Featured Article
Texas Children’s Hospital has delivered a novel gene therapy to treat Rett syndrome in two pediatric patients.
Precision Oncology Today
Magazine
Generative AI and Precision Medicine–The Future Is Not What It Used to Be
Generative AI is a new and rapidly emerging form of artificial intelligence that has the potential to revolutionize precision medicine by improving diagnosis, treatment, and drug discovery.
Pushing the Performance of Liquid Biopsies for Cancer with Nanotechnology
Nanotechnology opens the door to a range of unique methods for sensing cancer biomarkers in body fluids, thanks to the unusual properties and capabilities of nanoscale systems. Going small promises big gains in diagnosing and tracking a wide range of tumors.
Trending on Inside Precision Medicine
Alto Neuroscience Gets One Step Closer to Precision Depression Treatment
A third positive Phase II trial will help Alto Neuroscience progress precision psychiatry treatments for depression to the clinic.
Seattle Children’s CAR T Spinout BrainChild Bio Launches with a Focus on Pediatric CNS...
Research hospital Seattle Children’s announced today the spinout of its for-profit company BrainChild Bio, Inc., which will develop CAR T-cell therapies targeting pediatric central nervous system (CNS) cancers.
Texas Children’s Hospital Delivers First Gene Therapy for Rett Syndrome
Texas Children’s Hospital has delivered a novel gene therapy to treat Rett syndrome in two pediatric patients.
